As cancer therapies improve and increasingly achieve cures or recurring periods of remission, preventing and managing damage to organs from cancer treatment has become a top concern. That includes injury to the heart, says Joerg Herrmann, M.D., a cardiologist and the founder and director of the
Heart
Novartis today convened leading experts from science, policy, patient advocacy, and clinical care to spotlight elevated lipoprotein(a), or Lp(a) – a little-known but highly prevalent genetic risk factor for cardiovascular disease (CVD) that affect 1 in 5 people worldwide.1 The global educational webinar, titled “Introducing the Little (a) with Big Consequences”, was
DEAR MAYO CLINIC: I’ve been diagnosed with atrial fibrillation. I’ve read that it puts me at greater risk of stroke. Can you tell me more about this? ANSWER: You may not have known you had atrial fibrillation (AFib) until your condition was discovered during a physical examination. For others, AFib can have life-altering symptoms that affect […]
Around the world, people are starting to engage in outdoor activities after a winter spent largely indoors and perhaps with less physical activity than during more temperate seasons. In other climates, people may be starting an indoor, less-active time. Gosia Wamil, M.D., Ph.D., a cardiologist at Mayo Clinic Healthcare in London, offers five tips to […]
Aster Hospital, Mankhool recently made a rare detection when a 51-year-old man presented himself with complaints of chest pain. Upon thorough medical investigation the man was diagnosed with an unusual heart condition known as cor triatriatum sinister, a rare anomaly resulting in a heart with three atria (upper chambers of the heart, most people have […]














